Hadassah

Hadassah Genetic Discovery Article Singled Out for Recognition

Monday, Feb 8 2016

The January 2015 article which describes the Hadassah Medical Center’s discovery and cure of a rare genetic blood disease which appeared in Blood, the journal of the American Society of Hematology, has been chosen by the journal as one of ten outstanding publications for 2015.

The articles are selected based on the quality of the work, interest to the field of hematology, the number of citations, and how often the paper was accessed.

In this Hadassah article entitled “Early-Onset Evans Syndrome, Immunodeficiency and Premature Immunosenescence Associated with Tripeptidyl-Peptidase II Deficiency,” Dr. Paulina Stepensky, Bone Marrow Specialist and Senior Physician in Hemato-Oncology, along with her colleagues at Hadassah and in Germany, describe a potentially fatal protein deficiency which leads to immune system problems and a variable propensity toward viral infection.

As they reveal, it is the deficiency of this TPP2 molecule that leads T and B immune system cells to deteriorate prematurely (immunosenescence) and for the patient’s immune system to attack itself (autoimmunity). As the authors state, “TPP2 deficiency is the first primary immunodeficiency linking premature immunosenescence to severe autoimmunity.”

The medical scenario began when Hadassah’s physicians encountered the case of a 21-month-old Palestinian boy with early-onset Evans syndrome (autoimmune anemia), viral infections, and progressive leukopenia (reduction in white blood cells). An older sibling, a girl, had been followed in another hospital from the age of 18 months when she presented with white blood cell loss and anemia. She was treated with intravenous immunoglobulin and steroids, but became increasingly unresponsive to therapy at the age of 33 months. At 37 months, she passed away.

Through gene sequencing, Dr. Stepensky, along with Prof. Orly Elpeleg, head of Hadassah’s Department of Genetic and Metabolic Diseases, identified the damaged gene that led to the TPP2 deficiency. With the help of German researchers, the physicians were able to characterize the mechanism of the disease and the way TPP2 is involved in the proper functioning of the immune system. As Dr. Stepensky explains, “We actually discovered a new mechanism of the immune system, a previously unknown path that leads to premature aging of the immune system, which both allows us to diagnose this disease and will also help us better understand the whole system.”

The boy underwent a stem cell transplant at Hadassah, with donor cells from a healthy sibling. In October 2014, six months after the transplant, his physicians reported that “the child remains well with no infectious, autoimmune or lymphoproliferative manifestations. He is no longer prescribed any immunosuppressive medication. Thus, at this early time point, the clinical features that led to the decision to transplant have resolved.”

The physicians conclude that “the determination of senescent T and B cells should be part of the diagnostic evaluation of any child with refractory multilineage cytopenias (reduction in blood cells).”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Dec 15 2017

The Pediatric Intensive Care Unit (PICU) at Hadassah Hospital

An intimate video tour of the Pediatric Intensive Care Unit (PICU) at Hadassah Hospital highlights the miraculous recoveries of children given a second chance, with firsthand accounts from their grateful parents and their extraordinary doctors and nurses.

READ MORE ›
alt_text

Tuesday, Dec 12 2017

Hadassah Mount Scopus Rehab Gets Boost at Hadassah International Israel Gala Dinner

More than a thousand Israelis expressed their support for the eagerly anticipated new Hadassah Hospital Mount Scopus rehabilitation center for wounded soldiers and terror survivors at a gala event sponsored by Hadassah International Israel at the David International Hotel in Tel Aviv.

READ MORE ›
alt_text

Tuesday, Dec 12 2017

Older People Who Get Out Live Longer

A study led by Hadassah Physician Dr. Jeremy Michael Jacobs, Chair of the Hadassah Medical Organization’s Geriatric and Rehabilitation Complex, reveals that individuals between the ages of 70 and 90 who leave the house daily have a lower risk of mortality, independent of social, functional or medical status.

READ MORE ›
alt_text

Monday, Dec 11 2017

Twin boy Saved by Hadassah Experts and Cutting-Edge Technology

Simcha and his twin sister, Sarah, were born to a Jerusalem couple in their early forties, after years of hoping for children.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More